ENTITY
Bloomage Biotechnology

Bloomage Biotechnology (963 HK)

30
Analysis
Materials • China
Bloomage Biotechnology is a global biotechnology and biomaterial company specializing in the research, development, production, and application of bioactive substances, primarily hyaluronic acid and its derivatives. These products serve the pharmaceuticals, medical devices, cosmetics, and food/nutrition industries. The company was founded in 2000 and is headquartered in Jinan, Shandong, China.
more
bullish•Mao Geping Cosmetics
•10 Dec 2024 05:44

Mao Geping Cosmetics IPO Trading - Highest Demand for This Year

Mao Geping Cosmetics raised around US$345m in its Hong Kong IPO, after pricing at the top-end and upsizing the deal. In this note, we talk about...

Logo
628 Views
Share
bullish•Mao Geping Cosmetics
•04 Dec 2024 09:50

Mao Geping Cosmetics IPO - Low to Mid-End Looks Reasonable

Mao Geping Cosmetics is looking to raise up to US$270m in its upcoming Hong Kong IPO. In this note, we take a quick look at valuations.

Logo
807 Views
Share
bullish•Mao Geping Cosmetics
•12 Jun 2024 14:14

Mao Geping Cosmetics Pre-IPO - Riding on the Founder’s Reputation

Mao Geping Cosmetics is looking to raise around US$300m in its upcoming Hong Kong IPO. In this note, we talk about the company's past performance.

Logo
759 Views
Share
bearish•Honasa Consumer
•02 May 2024 10:45

Honasa Consumer IPO Lock-Up Expiry - US$500m+ Lockup Expiry with Everyone Well in the Money

Honasa Consumer (HONASA IN) raised about US$200m in its India IPO. Its pre-IPO investors will be released from its IPO linked lockup soon.

Logo
403 Views
Share
bullish•Mao Geping Cosmetics
•18 Apr 2024 07:00

Mao Geping Cosmetics Pre-IPO Tearsheet

Mao Geping Cosmetics (1478187D CH) is looking to raise around US$300m in its upcoming Hong Kong IPO. The bookrunner on the deal is CICC.

Logo
801 Views
Share
x